Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: A 13-year prospective study

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 1, 2005, Pages 39-48

  Hirschowitz, Basil I ^a   Simmons, Julie ^a   Mohnen, Jean ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PEPSIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG RESPONSE; DUODENUM ULCER; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTROSCOPY; HEARTBURN; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PEPSIN SECRETION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RECURRENCE RISK; RISK FACTOR; STOMACH ACID SECRETION; STOMACH ANTRUM RESECTION; STOMACH DISEASE; STOMACH HYPERSECRETION; STOMACH LESION; STOMACH PAIN; TREATMENT OUTCOME; ULCER PERFORATION; VOMITING; WEIGHT REDUCTION; WOUND HEALING; ZOLLINGER ELLISON SYNDROME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-ULCER AGENTS; DUODENAL ULCER; ESOPHAGITIS; FEMALE; GASTRIC ACID; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ZOLLINGER-ELLISON SYNDROME;

EID: 11844284899     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00606-8     Document Type: Article

References (40)

1. B.I. Hirschowitz, J. Simmons, J. Mohnen Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors a prospective 10-year study Aliment Pharmacol Ther 15 2001 1795 1806
2. B. Hirschowitz, J. Mohnen, S. Shaw Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h Aliment Pharmacol Ther 10 1996 497 506
3. P.M. Kirkpatrick, B.I. Hirschowitz Duodenal ulcer with unexplained marked basal gastric acid hypersecretion Gastroenterology 79 1980 4 10
4. D. O'Toole, M. Mignon, P. Ruszniewski The place of proton pump inhibitors in the management of the Zollinger-Ellison syndrome C. Scarpignato Frontiers in gastroenterology proton pump inhibitors 2004 Karger AG, Basel Basel, Switzerland In Press
5. H.C. Weber, D.J. Venzon, J.T. Lin Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome a prospective long-term study Gastroenterology 108 1995 1637 1649
6. D.L. Fraker, J.A. Norton, H.R. Alexander Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma Ann Surg 220 1994 320 330
7. B.E. Stabile, E. Passaro Jr Benign and malignant gastrinoma Am J Surg 149 1985 144 150
8. F. Yu, D.J. Venzon, J. Serrano Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome J Clin Oncol 17 1999 615 630
9. J.A. Norton, D.L. Fraker, H.R. Alexander Surgery to cure the Zollinger-Ellison syndrome N Engl J Med 341 1999 635 644
10. V.A. Fishbeyn, J.A. Norton, R.A. Benya Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome the best approach Ann Intern Med 119 1993 199 206
11. J.R. Pisegna, J.A. Norton, G.G. Slimak Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome Gastroenterology 102 1992 767 778
12. D.C. Metz, R.V. Benya, V.A. Fishbeyn Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection Aliment Pharmacol Ther 7 1993 247 257
13. H.C. Weber, D.J. Venzon, R.T. Jensen Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy Gastroenterology 112 1997 84 91
14. B. Hirschowitz, J. Mohnen, S. Shaw Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome Aliment Pharmacol Ther 10 1996 507 522
15. B.I. Hirschowitz Clinical course of nonsurgically treated Zollinger-Ellison syndrome M. Mignon R.T. Jensen Endocrine tumors of the pancreas recent advances Volume 23 1994 S Karger AG Basel, Switzerland 360 371
16. B.I. Hirschowitz, M.M. Haber Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole Aliment Pharmacol Ther 15 2001 87 103
17. B.I. Hirschowitz, J. Groarke Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls Dig Dis Sci 38 1993 1874 1884
18. B.I. Hirschowitz A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis Gastroenterology 101 1991 1140 1158
19. B.I. Hirschowitz Normal function of stomach D.Y. Graham Gastritis 1999 Lippincott-Raven Publishers Philadelphia 9 31
20. L.S. Miller, R. Vinayek, H. Frucht Reflux esophagitis in patients with Zollinger-Ellison syndrome Gastroenterology 98 1990 341 346
21. D.C. Metz, D.B. Strader, M. Orbuch Use of omeprazole in Zollinger-Ellison syndrome a prospective nine-year study of efficacy and safety Aliment Pharmacol Ther 7 1993 597 610
22. D.C. Metz, J.R. Pisegna, V.A. Fishbeyn Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high Gastroenterology 103 1992 1498 1508
23. P.N. Maton, R. Vinayek, H. Frucht Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome a prospective study Gastroenterology 97 1989 827 836
24. H. Frucht, P.N. Maton, R.T. Jensen Use of omeprazole in patients with Zollinger-Ellison syndrome Dig Dis Sci 36 1991 394 404
25. D.C. Metz, J.R. Pisegna, G.L. Ringham Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome Dig Dis Sci 38 1993 245 256
26. B.I. Hirschowitz, J. Simmons, J. Mohnen Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors Aliment Pharmacol Ther 16 2002 303 313
27. B.I. Hirschowitz, J.L. Simmons, L.F. Johnson Risk factors for esophagitis in extreme acid hypersecretors with and without Zollinger-Ellison syndrome Clin Gastrol Hepatol 2 2004 220 229
28. H.R. Koelz, R. Birchler, A. Bretholz Healing and relapse of reflux esophagitis during treatment with ranitidine Gastroenterology 91 1986 1198 1205
29. K.D. Bardhan Is there any acid peptic disease that is refractory to proton pump inhibitors Aliment Pharmacol Ther 7 1993 13 24
30. R.H. Holloway, J. Dent, F. Narielvala Relationship between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis Gut 38 1996 649 654
31. N. Chiba, C.J. De Gara, J.M. Wilkinson Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease a meta-analysis Gastroenterology 112 1997 1798 1810
32. P.N. Maton Management of Zollinger-Ellison syndrome Gastroenterologist 2 1994 111 118
33. J.W. Freston Omeprazole, hypergastrinemia, and gastric carcinoid tumors Ann Intern Med 121 1994 232 233
34. L. Laine, D. Ahnen, C. McClain Review article potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors Aliment Pharmacol Ther 14 2000 651 668
35. P.K. Roy, D.J. Venzon, K.M. Feigenbaum Gastric secretion in Zollinger-Ellison syndrome correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature Medicine 80 2001 189 222
36. P.N. Maton, H. Frucht, R. Vinayek Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery a prospective study Gastroenterology 94 1988 294 299
37. S. Xue, P.O. Katz, B. Banerjee Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors Aliment Pharmacol Therap 15 2001 1351 1356
38. G. Paul, A. Ramdani, M. Mignon Comparative efficacy of lansoprazole and omeprazole on the intragastric pH over a period of 24 hr and on the basal acid output in 9 patients with Zollinger-Ellison (French) Gastroenterol Clin Biol 18 1994 695 701
39. D.J. Hetzel, J. Dent, W.D. Reed Healing and relapse of severe peptic esophagitis after treatment with omeprazole Gastroenterology 95 1988 903 912
40. M. Mignon, P. Jais, G. Cadiot Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome M. Mignon R.T. Jensen Endocrine tumors of the pancreas: recent advances in research and management series: frontiers of gastrointestinal research 1995 S Karger Basel, Switzerland 223 239